Impact of Patient Education on Plasma Concentrations and Effectiveness of Posaconazole Oral Suspension Under Clinical Conditions

Basic and Clinical Pharmacology and Toxicology - United States
doi 10.1111/bcpt.13093
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Treatment by Posaconazole Tablets Did Not Reduced Variability of Posaconazole Trough Concentrations Compared to Posaconazole Suspension

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Posaconazole Therapeutic Drug Monitoring in Clinical Practice and Longitudinal Analysis of the Effect of Routine Laboratory Measurements on Posaconazole Concentrations

Mycoses
DermatologyMedicineInfectious Diseases
2019English

Impact of Pharmacist Led Anticoagulation Monitoring and Patient Education on Oral Anticoagulation Therapy With Acenocoumarol

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2017English

Superior Serum Concentrations With Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

Plasma and Myocardial Digoxin Concentrations in Patients on Oral Therapy.

Heart
Cardiovascular MedicineCardiology
1969English

Alterations of Plasma Apolipoprotein A-Iv Levels Under Various Clinical Conditions

The Journal of Japan Atherosclerosis Society
1986English

High Intracellular Concentrations of Posaconazole Do Not Impact on Functional Capacities of Human Polymorphonuclear Neutrophils and Monocyte-Derived MacrophagesIn Vitro

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Plasma Concentrations of Posaconazole Administered via Nasogastric Tube in Patients in a Surgical Intensive Care Unit

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2012English

Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives

Vascular Health and Risk Management
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy